About

Gunilla Petersson, PhD, Senior Advisor to Nanoform, founded Inhaled Drug Delivery Consulting AB after a 30-year career at AstraZeneca, where she held leading roles in product development and inhaled drug delivery. Her expertise covers analytical testing, formulation development, device development, patient use of devices, regulatory documentation and development processes.

She also consults on matters of due diligence, provides support to scientific marketing, intellectual property and business development, while also consulting as a general inhalation specialist. She has served on the boards of the European Pharmaceutical Aerosol Group and of the International Pharmaceutical Aerosol Consortium on Regulation & Science, and is currently on the board of Medicon Valley Inhalation Consortium.

Contributions

PULMONARY

EXPANDING OPPORTUNITIES FOR INHALED DRUG DELIVERY

Dr Gunilla Petersson considers the challenges associated with efficiently delivering drugs to the lungs and the potential of nanoparticle-based formulations to achieve high lung deposition of small molecules and biologics, using gentle particle processing techniques that enable the delivery of sensitive drugs.

More contributions

EXPERT VIEW

PIPELINE TRENDS AND CHALLENGES IN PULMONARY DELIVERY

Gunilla Petersson provides an overview of the inhalables sector from a pharma perspective, covering the three major device types – DPIs, pMDIs and nebulisers.